Method for sterilizing recombinant human serum albumin pharmaceutical preparation
US5691451A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Oct 26, 1994 |
| Grant date | Nov 25, 1997 |
| Priority date | — |
| Expiry date | Oct 26, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A recombinant human serum albumin (rHSA) pharmaceutical preparation is sterilized by subjecting a pharmaceutical preparation of rHSA obtained by gene manipulation techniques packed in a container in an administration unit to heat treatment at 50.degree. to 80.degree. C. for 30 minutes or more. By the disclosed method, rHSA having high safety can be provided since microorganisms contaminated in rHSA pharmaceutical preparations die as a result of the sterilization method of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.